Investment from Allen Law’s Seveno Capital reflects growing demand for insight, infrastructure and scale in the longevity economy.
The longevity sector has received a fresh signal of investor confidence this week, as we announce that Seveno Capital has taken a strategic stake in Longevity.Technology, the online platform known for its data-led insight, dealflow intelligence and coverage of science-led innovation in aging and healthspan. The investment forms part of a wider $70 million commitment by Seveno Capital to early and growth-stage ventures in the longevity, wellness and fitness space – a portfolio that reflects both commercial opportunity and a deeper mission to extend access to health-optimizing solutions.
Seveno Capital was founded by healthspan entrepreneur and investor Allen Law, whose expanding ecosystem of companies and investments straddles fitness, holistic wellness, hospitality and longevity. Law’s interests are underpinned by a coherent strategy: to foster the convergence of hospitality, fitness, holistic wellness, technology and longevity, and to help scale solutions that can move longevity from theory to application.
The interconnected nature of Law’s ventures – spanning fitness brands, wellness services and planned longevity medicine clinics – is central to this approach. Each business and investment complements and amplifies the others, creating what he refers to as a ‘network effect’ that accelerates both commercial scaling and ecosystem-building.
Based in Singapore and active globally, Law is increasingly seen as a bellwether in this emerging longevity space – and for good reason. His investments are not speculative; they are calculated, closely aligned with operational insight, and often foreshadow wider worldwide trends and opportunities. If Allen Law is backing a platform, others may well pay attention.
In his twenties, Law grew Park Hotel Group from a single hotel into one of the most prestigious hotel groups in Asia. In 2023, his pivot into health and wellness led him to co-found MOVE[REPEAT] which grew rapidly into a collective of 50 studios across five countries; fitness group REVL Training is planning to grow six fold following Law’s investment.
In May 2025, his Seveno Capital announced the launch of Longevity World, an 80,000 sq ft hub for longevity in the heart of Singapore. In addition, Singapore’s longevity ambitions were further highlighted with the recent launch of Morrow, Law’s flagship which is backed by a $156m investment to develop advanced clinics in the city-state. Underscoring both the influx of capital into longevity infrastructure and the region’s determination to establish itself as a global hub for healthspan innovation, the launch also aligns with Law’s broader ambition to help shape Southeast Asia’s role as a leader in the emerging global longevity economy.
Longevity.Technology: The decision to invest in a platform like Longevity.Technology reflects a maturing perspective on the role that intelligence and infrastructure play in the growth of emerging sectors. As longevity continues its shift from a collection of siloed innovations to a coherent, investible ecosystem, the need for curated insight, reliable data and informed connectivity becomes increasingly apparent. Backing a platform that sits at the intersection of science, investment and opportunity suggests a recognition that progress in this field depends not only on breakthrough discoveries, but on the systems that enable those discoveries to find capital, partners and markets.
In this context, longevity intelligence is no longer a passive observer – it is becoming a strategic enabler. Just as bioinformatics was essential to the development and eventual commercialisation of genomics, platforms that can translate complexity into clarity are now vital to shaping where and how innovation happens. For investors navigating the breadth of the longevity economy – from cellular rejuvenation to digital biomarkers and healthspan-focused therapeutics – access to well-structured insight is a differentiator. This investment is a signal that such infrastructure is not only valuable, but necessary for the sector to scale responsibly and effectively.
Infrastructure, insight and access
For Law, the investment in Longevity.Technology complements a broader objective. “The global longevity revolution is one of the defining investment themes of our time,” he told us. “It will be as transformational to everyday life, and as significant an entrepreneurial and investment opportunity, as the global AI revolution. Despite this, longevity garners far less media attention than AI. Platforms like Longevity.Technology therefore play a globally vital role in driving visibility, intelligence and connectivity – accelerating not just commercial progress, but also broader access to the benefits of longevity.”
Law is also motivated by a more personal ambition: to narrow the persistent 9–10 year global gap between lifespan and healthspan. His entrepreneurial activities and commercial investments are shaped by a dual social purpose – not just to derive financial return but also to make fitness, holistic wellness and longevity solutions accessible to vast numbers of individuals outside the narrow confines of the world’s wealthiest one percent.
This reflects a shift that has become more visible across the longevity sector in recent years: while scientific momentum continues to build, infrastructure is increasingly being recognised as essential to scale, translation and adoption. Without informed connectivity – between researchers and investors, clinicians and entrepreneurs – even the most promising breakthroughs risk losing traction.
Media and data platforms that sit at this junction can help shape where capital flows, which science is surfaced and how early-stage companies gain the credibility and exposure they need. A strong platform not only reports on the longevity sector – it helps make the sector investible.
Supporting growth through intelligence
Longevity.Technology was launched with this very goal: to help bring structure and clarity to a complex, multidisciplinary space. Its focus on market analysis, curated news and investment opportunities has positioned it as a key node in the growing network of longevity activity – a role likely to grow in importance as regulatory, financial and scientific pressures converge.
“Since 2019, we have been dedicated to consolidating the diverse narratives within the longevity industry into one coherent and professional destination, helping to establish this sector as both recognizable and investable,” said Phil Newman, CEO and Founder of Longevity.Technology. “Having played a central role in fulfilling this mission, we are now doubling down to solidify our #1 status and prime the industry for increased capital flows and accelerated growth. With the strategic backing of Seveno Capital, whose vision for scalable, accessible healthspan solutions aligns deeply with ours, we are better positioned than ever to drive impact and innovation across the longevity ecosystem.
“In Q4 2025, we will publicly release our datasets alongside our new agenticAI-enabled system, which will be the first M&A and investment platform specifically for longevity biotech. The reach of our data intelligence will allow us to significantly expand our news output and insights as we continue to develop our systems. Our successful events program, in partnership with Founders Forum, will see an expanded rollout of our highly curated networking events. On the consumer side, we are making our outstanding supplements range, FLT.life, more widely available, while also adapting our media and content coverage for social platforms to share our deep knowledge and increase engagement.
“I have never been more confident in our position as the leading news and knowledge-sharing platform for the longevity industry, and – with Seveno Capital’s support – we are committed to strengthening our leadership as the field continues to grow.”
As the sector continues to expand and diversify – both in terms of geography and science – the importance of infrastructure will only increase. According to UBS, the global longevity economy could be worth $8 trillion by 2030 – a figure that reflects both demographic momentum and the growing convergence of sectors now engaging with aging and healthspan [1]. Science may form the core of the longevity economy, but systems, connections and insight are what enable it to thrive.
[1] https://www.ubs.com/us/en/wealth-management/insights/market-news/article.2048635.html
